← Back to headlines
Lundbeck Reports Early Success for Experimental Cushing's Disease Treatment
Pharmaceutical company Lundbeck has announced early positive results for its experimental treatment for Cushing's disease, a rare endocrine disorder.
14 Jun, 20:24 — 14 Jun, 20:24
Sources
Showing 1 of 1 sources
